Source - RNS
RNS Number : 9458L
EKF Diagnostics Holdings PLC
07 October 2016


EKF Diagnostics Holdings plc

("EKF", the "Company")


Trading update


EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that trading in Q3 of the current financial year was materially higher than budget and at a run-rate in excess of market forecasts. As a result the Company is now confident of achieving revenues and adjusted EBITDA for 2016 which will exceed the high end of current market forecasts.


In addition, the Company announces that cash generation during the quarter has been strong and its net debt position has improved considerably. While the Company plans to continue investing during Q4 and early 2017 in capital expenditure to increase consumables capacity in Germany and to replace equipment in the USA, it now expects to be cash positive within the next 12 months.


This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.


EKF Diagnostics Holdings plc

Christopher Mills, Non-Executive Chairman

Tel: 029 2071 0570

Julian Baines, CEO 

Richard Evans, FD & COO

Panmure Gordon (UK) Limited (NOMAD & Joint Broker)

Tel: 020 7886 2500

Freddy Crossley / Peter Steel (Corporate Finance)

N+1 Singer (Joint Broker)

Tel: 020 7496 3000

Alex Price / Alex Laughton-Scott

Walbrook PR Limited

Tel: 020 7933 8780 or [email protected]  

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303


This information is provided by RNS
The company news service from the London Stock Exchange